Therapeutic vaccine to cure large mouse hepatocellular carcinomas

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. Here we report the development of a therapeutic vaccination regimen (shortened as ‘TheraVac’) consisting of intratumoral delivery of high-mobility group nucleosome-binding protein 1 (HMG...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Zhen, Yang, De, Trivett, Anna, Oppenheim, Joost J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581012/
https://www.ncbi.nlm.nih.gov/pubmed/28881713
http://dx.doi.org/10.18632/oncotarget.19367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581012/
https://www.ncbi.nlm.nih.gov/pubmed/28881713
http://dx.doi.org/10.18632/oncotarget.19367

Ejemplares similares